|
Volumn 17, Issue 9, 2011, Pages 1435-1438
|
Evaluation of a commercial microarray as a confirmation test for the presence of extended-spectrum β-lactamases in isolates from the routine clinical setting
a
SALTRO
(Netherlands)
|
Author keywords
Check points; Clinical setting; Confirmation test; ESBL; Microarray
|
Indexed keywords
BETA LACTAMASE CTX M;
BETA LACTAMASE SHV;
BETA LACTAMASE TEM;
CEFOTAXIME;
CEFTAZIDIME;
EXTENDED SPECTRUM BETA LACTAMASE;
HYDROLASE;
UNCLASSIFIED DRUG;
ARTICLE;
BACTERIUM ISOLATE;
CLINICAL EVALUATION;
CLINICAL LABORATORY;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DNA ISOLATION;
DNA SEQUENCE;
ENTEROBACTER CLOACAE;
ESCHERICHIA COLI;
FALSE NEGATIVE RESULT;
HUMAN;
KLEBSIELLA OXYTOCA;
KLEBSIELLA PNEUMONIAE;
MICROARRAY ANALYSIS;
MINIMUM INHIBITORY CONCENTRATION;
NETHERLANDS;
NONHUMAN;
POLYMERASE CHAIN REACTION;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PROTEIN MICROARRAY;
PROTEUS MIRABILIS;
SCREENING TEST;
SENSITIVITY AND SPECIFICITY;
|
EID: 80051906946
PISSN: 1198743X
EISSN: 14690691
Source Type: Journal
DOI: 10.1111/j.1469-0691.2011.03567.x Document Type: Article |
Times cited : (14)
|
References (6)
|